CTRI/2023/01/049287尚未招募未知
Post Approval Concurrent Observational Study to Assess Safety Clinical Utilization and Effectiveness of BISOprolol in the treatment of Coronary ARtery Disease undergoing PCI(BISOCARD Study) - BISOCARD Study
Torrent Pharmaceuticals Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1 Male or female patients 18 to 59 years
- •2 Known CAD cases requiring Bisoprolol
- •3 Known CAD cases with Comorbidities such as
- •Hypertension or Diabetes
- •4 Patients willing follow up for 24 week at the same centre
排除标准
- •1 Hypersensitivity to Bisoprolol
- •2 Acute heart failure or during episodes of heart failure decompensation requiring IV Inotropic therapy
- •3 Cardiogenic shock
- •4 Second or third degree AV block
- •5 Sick sinus syndrome
- •6 Hepatic enzyme elevation X3 ULN
- •7 For women only currently pregnant confirmed with positive pregnancy test or breast feeding
- •8 Sexually active woman of childbearing age not practicing accepted birth control method
研究者
相似试验
尚未招募
4 期
Study to check the result and safety of combination treatment of vildagliptin and dapagliflozin in type 2 diabetes mellitus patientCTRI/2022/08/044757Torrent Pharmaceuticals Ltd
尚未招募
不适用
Study to check the safety and effectiveness of Sitagliptin and Dapagliflozin combination in Type 2 Diabetes patients with heart problemsCTRI/2022/09/045218Torrent Pharmaceuticals Ltd
招募中
不适用
Observational study to check the effectiveness and safety of Remoglifozin in high risk patients with type 2 Daibetes Mellitus.CTRI/2022/01/039072Torrent Pharmaceuticals Ltd
尚未招募
Unknown
Study on the Effectiveness and Safety of Once-Daily Brivaracetam for Drug-Resistant Focal Onset EpilepsyCTRI/2024/07/070210Torrent Pharmaceuticals Ltd
尚未招募
Unknown
To evaluate the efficacy and safety assessment of Nicorandil in ASCVD with AnginaCTRI/2024/01/061624Torrent Pharmaceutical Ltd